Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.
Northwestern Medicine scientists have discovered why Huntington’s is so toxic to cancer cells and harnessed it for a novel approach to treat cancer, a new study reports.
Huntington’s is caused by an over abundance of a certain type of repeating RNA sequences in one gene, huntingtin, present in every cell. The defect that causes the disease also is highly toxic to tumor cells. These repeating sequences — in the form of so-called small interfering RNAs — attack genes in the cell that are critical for survival. Nerve cells in the brain are vulnerable to this form of cell death, however, cancer cells appear to be much more susceptible.
“This molecule is a super assassin against all tumor cells,” said senior author Marcus Peter, the Tom D. Spies Professor of Cancer Metabolism at Northwestern University Feinberg School of Medicine. “We’ve never seen anything this powerful.”
Huntington’s disease deteriorates a person’s physical and mental abilities during their prime working years and has no cure.
The study will be published Feb. 12 in the journal EMBO Reports.
To test the super assassin molecule in a treatment situation, Peter collaborated with Dr. Shad Thaxton, associate professor of urology at Feinberg, to deliver the molecule in nanoparticles to mice with human ovarian cancer. The treatment significantly reduced the tumor growth with no toxicity to the mice, Peter said. Importantly, the tumors did not develop resistance to this form of cancer treatment.
Peter and Thaxton are now refining the delivery method to increase its efficacy in reaching the tumor. The other challenge for the scientists is figuring out how to stabilize the nanoparticles, so they can be stored.
First and co-corresponding author Andrea Murmann, research assistant professor in medicine at Feinberg, also used the molecule to treat human and mouse ovarian, breast, prostate, liver, brain, lung, skin and colon cancer cell lines. The molecule killed all cancer cells in both species.
The Huntington’s cancer weapon was discovered by Murmann, who had worked with Peter on earlier research that identified an ancient kill-switch present in all cells that destroys cancer.
“I thought maybe there is a situation where this kill switch is overactive in certain people, and where it could cause loss of tissues,” Murmann said. “These patients would not only have a disease with an RNA component, but they also had to have less cancer.”
She started searching for diseases that have a lower rate of cancer and had a suspected contribution of RNA to disease pathology. Huntington’s was the most prominent.
When she looked at the repeating sequences in huntingtin, the gene that causes the disease, she saw a similar composition to the earlier kill switch Peter had found. Both were rich in the C and G nucleotides (molecules that form the building blocks of DNA and RNA).
“Toxicity goes together with C and G richness,” Murmann said. “Those similarities triggered our curiosity.”
In the case of people who have Huntington’s, the gene huntingtin has too many repeating sequences of the triplet sequence CAG. The longer the repeating sequence, the earlier they will develop the disease.
“We believe a short-term treatment cancer therapy for a few weeks might be possible, where we could treat a patient to kill the cancer cells without causing the neurological issues that Huntington’s patients suffer from,” Peter said.
Peter also is co-leader of the Translational Research in Solid Tumors Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Huntington’s patients have a lifetime exposure to these toxic RNA sequences, but generally don’t develop symptoms of the disease until age 40, he noted.
Every child of a parent with Huntington’s has 50/50 chance of carrying the faulty gene. Today, there are approximately 30,000 symptomatic Americans and more than 200,000 at-risk of inheriting the disease.
Learn more: Huntington’s disease provides new cancer weapon
The Latest on: Cancer therapy
via Google News
The Latest on: Cancer therapy
- Global Cancer Targeted Therapy Market Top Companies Profiles, CAGR And Forecast Up To 2024on March 23, 2020 at 12:51 am
Final Report will add the analysis of the impact of COVID-19 on this industry" The report begins with a market overview capturing the significant facts of the “Cancer Targeted Therapy market”. It also ...
- Philadelphia biopharm company partners with Chinese firm to advance cancer therapyon March 22, 2020 at 8:13 pm
Context Therapeutics, a Philadelphia biopharmaceutical company focused on hormone-driven cancers, is teaming up with a Chinese biotech firm to advance the development of Context's lead new drug ...
- p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate canceron March 22, 2020 at 6:14 pm
All prices are NET prices. VAT will be added later in the checkout. Fig. 1: Class I HDACs inhibition increased PD-L1 expression in metastatic PCa cells. Fig. 2: Upregulated PD-L1 by HDAC inhibition ...
- Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasison March 22, 2020 at 4:07 pm
Stromal–tumour interactions facilitate pancreatic cancer (PC) progression. The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and ...
- Prostate cancer study finds molecular imaging could transform management of patients with aggressive canceron March 22, 2020 at 1:34 pm
Although the study did not assess whether the scans had any effect on patient survival, the researchers say this approach could improve outcomes by helping doctors decide whether to offer a localised ...
- Living with brain cancer has prepared me for coronaviruson March 22, 2020 at 7:07 am
With my illness, I’ve already have had to self-isolate several times. I’ve also learned a valuable lesson that others can now follow: Ask for help.
- Girl’s cancer treatment under threat from coronaviruson March 22, 2020 at 7:01 am
Eva Williams’s parents are raising money to send her to New York for pioneering treatment but may not be able to go due to travel restrictions.
- Cancer Cells Can't Withstand This Treatment's Medicinal 'Double-Strike'on March 22, 2020 at 4:43 am
Effective treatment options for these types of cancer become increasingly limited over time as tumours become resistant to chemotherapy after several rounds of treatment. For most patients, a cure is ...
- Cancer patients forced to delay treatment over coronavirus concernson March 20, 2020 at 5:05 pm
Hospitals across the country are now weighing whether clinical trials could expose vulnerable cancer patients and health workers to the coronavirus. Many are being asked to do appointments online, ...
- Statins might protect hearts from breast cancer chemoon March 20, 2020 at 1:12 pm
Cholesterol-lowering statins, commonly used to help prevent heart disease, could shield women's hearts from the harms of certain breast cancer drugs, a new study suggests.
via Bing News